Theoretical Study of the Hoogsteen-Watson-Crick Junctions in DNA
Overview
Authors
Affiliations
A series of d (AT)(n) oligonucleotides containing mixtures of normal B-type Watson-Crick and antiparallel Hoogsteen helices have been studied using molecular dynamics simulation techniques to analyze the structural and thermodynamic impact of the junction between Watson-Crick and antiparallel Hoogsteen structures. Analysis of molecular dynamics simulations strongly suggests that for all oligonucleotides studied the antiparallel Hoogsteen appears as a reasonable conformation, only slightly less stable than the canonical B-type Watson-Crick one. The junctions between the Watson-Crick and Hoogsteen structures introduces a priori a sharp discontinuity in the helix, because the properties of each type of conformation are very well preserved in the corresponding fragments. However, and quite counterintuitively, junctions do not largely distort the duplex in structural, dynamics or energetic terms. Our results strongly support the possibility that small fragments of antiparallel Hoogsteen duplex might be embedded into large fragments of B-type Watson-Crick helices, making possible protein-DNA interactions that are specific of the antiparallel Hoogsteen conformation.
Genna V, Portella G, Sala A, Terrazas M, Serrano-Chacon I, Gonzalez J Nucleic Acids Res. 2025; 53(5).
PMID: 40071936 PMC: 11897885. DOI: 10.1093/nar/gkaf170.
Force-Field-Dependent DNA Breathing Dynamics: A Case Study of Hoogsteen Base Pairing in A6-DNA.
Stone S, Ray D, Andricioaei I J Chem Inf Model. 2022; 62(24):6749-6761.
PMID: 36049242 PMC: 9795553. DOI: 10.1021/acs.jcim.2c00519.
Transient Hoogsteen Base Pairs Observed in Unbiased Molecular Dynamics Simulations of DNA.
Galindo-Murillo R, Cheatham 3rd T J Phys Chem Lett. 2022; 13(27):6283-6287.
PMID: 35775742 PMC: 9466961. DOI: 10.1021/acs.jpclett.2c01348.
Slow motions in A·T rich DNA sequence.
Ben Imeddourene A, Zargarian L, Buckle M, Hartmann B, Mauffret O Sci Rep. 2020; 10(1):19005.
PMID: 33149183 PMC: 7642443. DOI: 10.1038/s41598-020-75645-x.
Design strategies for programmable oligonucleotide nanotherapeutics.
Sahle F, Lowe T Drug Discov Today. 2019; 25(1):73-88.
PMID: 31525462 PMC: 6980509. DOI: 10.1016/j.drudis.2019.09.006.